Nantong First Peoples Hospital

Nantong, Jiangsu 226001

0 studies enrolling now · 2 studies all time

What they study most

Obesity, Overweight, Type 2 Diabetes, Unresectable or Metastatic Microsatellite Stable/Mismatch Repair Proficient Colorectal Cancer

Studies at this site

• A Study Investigating the Efficacy and Safety of Alcestobart (LBL-007) Plus Tislelizumab in Combination With Bevacizumab Plus Fluoropyrimidine Versus Bevacizumab Plus Fluoropyrimidine in Participants With Unresectable or Metastatic Colorectal Cancer — Running, not enrolling
• A Study of Orforglipron in Adult Participants With Obesity or Overweight and Type 2 Diabetes — Completed